1. Home
  2. BIPC vs APGE Comparison

BIPC vs APGE Comparison

Compare BIPC & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Infrastructure Corporation

BIPC

Brookfield Infrastructure Corporation

HOLD

Current Price

$42.12

Market Cap

4.6B

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$81.58

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIPC
APGE
Founded
2019
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.7B
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
BIPC
APGE
Price
$42.12
$81.58
Analyst Decision
Sell
Strong Buy
Analyst Count
1
13
Target Price
$45.00
$109.67
AVG Volume (30 Days)
1.3M
553.8K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
5.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.85
N/A
Revenue Next Year
$5.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.18
$34.34
52 Week High
$51.72
$95.32

Technical Indicators

Market Signals
Indicator
BIPC
APGE
Relative Strength Index (RSI) 59.38 46.94
Support Level $38.41 $80.52
Resistance Level $42.87 $86.42
Average True Range (ATR) 1.08 3.85
MACD 0.45 -0.38
Stochastic Oscillator 86.60 47.67

Price Performance

Historical Comparison
BIPC
APGE

About BIPC Brookfield Infrastructure Corporation

Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom, United States, France, Switzerland, Singapore, China, Denmark, Hong Kong, Germany and Others.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: